Member Info for cjulien

I think its most likely (for your 3 points) down to favorable terms you are able to get when negotiating with smaller partners as opposed more aggressive terms you may get with bigger ones...any bigger partner, big pharma, government would want to lock up significant upside and remove it from you... that being said im no expert and actually have no idea whether these partners are actually "small" as you describe them...

The 7 directors of the company will take these decisions and vote, not rm alone
https://www.synairgen.com/about-us/synairgens-directors/

Bruce, surely thats why they re planning to produce 100k treatments a month... why produce hundreds when you can waste tens of thousands...
Go deramp somewhere else

Didnt holgate mention he was very excited about the home trial results? I didnt attend but i think he mentioned that which must mean its either finished or closed to be

+1

Long live Holbrook

Cant wait for that victory pint with you guys

Yes these shares will be eligible for trading from monday...

seeing some approvals appearing in the media from EMA prime which wasnt announced on the website we ve been tracking...
which confirms that they wont announce it there for confidential reasons and we may see a RNS/annoucement soon...
http://www.pharmaceuticaldaily.com/valnevas-chikungunya-vaccine-candidate-awarded-ema-prime-designation/

except that with 80M in the bank and phase 3 trials starting (and everything else happening), you can argue that the prospects of the company have been greatly enhanced which should be reflected in the valuation.

its client restricted :(

840...

still with 50% bear case? meaning 820?

In fact read this article which explains why vaccines wont solve anything in the short-mid term
https://www.thelancet.com/journals/lanmic/article/PIIS2666-5247(20)30151-8/fulltext

Couldnt agree more

RNS tomorrow would be nice ;)

easier to get 900 eligible patients when spread geographically rather than focused on a specific location... and the logistics are handled by a third party expert

pmjh i think you refer to those dates: https://www.ema.europa.eu/en/documents/regulatory-procedural-guideline/prime-eligibility-requests-2020-deadlines-submission-timetable-assessment_en.pdf

Lets hope they submitted before august 26th, otherwise we re looking at the November meeting for final approval

a very interesting take on what to expect from vaccines... at least for the next few years
https://www.thelancet.com/journals/lanmic/article/PIIS2666-5247(20)30151-8/fulltext

i have probably refreshed this page 500 times already today
https://www.ema.europa.eu/en/news-events/whats-new